Cite
Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.
MLA
Woodward, Wendy A., et al. “Locoregional Recurrence after Doxorubicin-Based Chemotherapy and Postmastectomy: Implications for Breast Cancer Patients with Early-Stage Disease and Predictors for Recurrence after Postmastectomy Radiation.” International Journal of Radiation Oncology, Biology, Physics, vol. 57, no. 2, Oct. 2003, pp. 336–44. EBSCOhost, https://doi.org/10.1016/s0360-3016(03)00593-5.
APA
Woodward, W. A., Strom, E. A., Tucker, S. L., Katz, A., McNeese, M. D., Perkins, G. H., Buzdar, A. U., Hortobagyi, G. N., Hunt, K. K., Sahin, A., Meric, F., Sneige, N., & Buchholz, T. A. (2003). Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. International Journal of Radiation Oncology, Biology, Physics, 57(2), 336–344. https://doi.org/10.1016/s0360-3016(03)00593-5
Chicago
Woodward, Wendy A, Eric A Strom, Susan L Tucker, Angela Katz, Marsha D McNeese, George H Perkins, Aman U Buzdar, et al. 2003. “Locoregional Recurrence after Doxorubicin-Based Chemotherapy and Postmastectomy: Implications for Breast Cancer Patients with Early-Stage Disease and Predictors for Recurrence after Postmastectomy Radiation.” International Journal of Radiation Oncology, Biology, Physics 57 (2): 336–44. doi:10.1016/s0360-3016(03)00593-5.